As of 2026-03-25, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is -0.20 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 CAD, the upside of Algernon Pharmaceuticals Inc is -610.51%.
Based on its market price of 0.04 CAD and our intrinsic valuation, Algernon Pharmaceuticals Inc (AGN.CN) is overvalued by 610.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.20 - -0.20 | -0.20 | -610.51% |
| P/E | (0.00) - (0.00) | (0.00) | -105.1% |
| DDM - Stable | (0.29) - (14.31) | (7.30) | -18352.7% |
| DDM - Multi | (0.22) - (9.63) | (0.45) | -1235.4% |
| Market Cap (mil) | 1.89 |
| Beta | -0.52 |
| Outstanding shares (mil) | 47.33 |
| Enterprise Value (mil) | 1.68 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.10% |
| Cost of Debt | 5.00% |
| WACC | 6.39% |